CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Loading researcher profile…

Anonymous aggregate analytics use the connection IP transiently only to derive country; the IP is not stored in analytics data. DNT and GPC are honored, with 90-day retention. IP Geolocation by DB-IP.

CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Researchers/Profile

Researcher profile

Andreas Wenger

OPENALEX: A5008963165↗ORCID: 0000-0003-4818-4681↗

Affiliations

Organizations

Addiction Switzerlandauthorship · CH Swiss Re (Switzerland)authorship · CH University of Zurichauthorship · CH World Health Organizationauthorship · CH

Public evidence

5 connected articles

Efficacy of a Mobile Phone–Based Life-Skills Training Program for Addiction Prevention Optimized Among Adolescents With Low Program Engagement: Cluster-Randomized Controlled Trial2026 · PubMed Central Open Access Factors Influencing Engagement in a Digital Substance Use Prevention Program: Qualitative Study Using the Capability, Opportunity, Motivation Model and Theoretical Domains Framework.2025 · Europe PMC Comparing a mindfulness- and CBT-based guided self-help Internet- and mobile-based intervention against a waiting list control condition as treatment for adults with frequent cannabis use: a randomized controlled trial of CANreduce 3.0.2022 · PubMed Central Open Access Efficacy of a Mobile App-Based Coaching Program for Addiction Prevention among Apprentices: A Cluster-Randomized Controlled Trial2022 · PubMed Central Open Access Efficacy of a smartphone-based coaching program for addiction prevention among apprentices: study protocol of a cluster-randomised controlled trial.2020 · PubMed Central Open Access

Matched by exact identifiers only. Profile data: Corpus/OpenAlex.

Andreas Wenger - Medical Cannabis Research Engine